phrykt

Option Care Health, Inc. (OPCH): who owns it and who trades it

As of Nov 16, 2026, OPCH insiders reported 4 open-market sales worth $1.4M and 4 purchases worth $1.9M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was R Carter Pate (Director), with $1.2M. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Option Care Health

From the latest filings

Overall: about as much buying as selling. Famous investors mostly sold. Funds and insiders were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns OPCH

372 funds and institutions reported OPCH shares worth $3.5B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 14.1%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.14.1%
Wellington Management Group LLP7.5%
Vanguard Portfolio Management LLC5.3%
Fuller & Thaler Asset Management, Inc.4.7%
Vanguard Capital Management LLC4.5%
Durable Capital Partners LP3.9%
State Street Corp3.9%
Arrowstreet Capital, Limited Partnership3.8%
Dimensional Fund Advisors LP3.5%
Geode Capital Management, LLC2.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.22.10M14.08%$464M+11%
Wellington Management Group LLP11.78M7.50%$247M-1%
Vanguard Portfolio Management LLC8.27M5.27%$174M+3%
Fuller & Thaler Asset Management, Inc.7.45M4.74%$156M+5%
Vanguard Capital Management LLC7.06M4.50%$148M+1%
Durable Capital Partners LP6.16M3.93%$129M-31%
State Street Corp6.14M3.91%$129M+5%
Arrowstreet Capital, Limited Partnership5.98M3.81%$125M+41%
Dimensional Fund Advisors LP5.45M3.47%$114M+41%
Geode Capital Management, LLC4.47M2.85%$93.7M+5%
California State Teachers Retirement System3.76M2.40%$179M+1942%
Millennium Management LLC2.62M1.67%$54.9M+60%
Charles Schwab Investment Management Inc2.46M1.57%$51.7M-1%
Sixth Street Partners Management Company, L.P.2.46M1.57%$51.7M–
Bank of America Corp2.27M1.44%$47.5M+17%
Morgan Stanley2.24M1.43%$47M-20%
Van Berkom & Associates Inc.2.19M1.39%$45.8M-31%
Goldman Sachs Group Inc2.17M1.38%$45.4M+58%
Sumitomo Mitsui Trust Group, Inc.2.13M1.36%$44.7M-18%
Northern Trust Corp1.96M1.25%$41.1M+1%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, OPCH insiders reported $1.9M of open-market purchases and $1.4M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$1.9M
4 trades, 4 people
Sales, 12 months
$1.4M
4 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 11, 2026
Filed Nov 12, 2026

Purchases and sales by month

$1.9M$1.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 11, 2026R Carter PateDirectorSale400$31.65$12.7KForm 4
Nov 10, 2026R Carter PateDirectorSale6,092$31.65$193KForm 4
May 7, 2026Timothy P SullivanDirectorPurchase24,154$20.69$500KForm 4
May 4, 2026Harry M Jansen Kraemer JrDirectorPurchase36,610$21.41$784KForm 4
May 4, 2026Meenal SethnaCFOPurchase16,225$20.16$327KForm 4
May 4, 2026John Charles RademacherCEOPurchase12,500$21.18$265KForm 4
Feb 27, 2026R Carter PateDirectorSale30,287$32.05$971KForm 4
Feb 27, 2026Michael BavaroChief Human Resources OfSale6,000$33.00$198KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
R Carter PateDirector–$1.2MNov 11, 2026
Harry M Jansen Kraemer JrDirector$784K–May 4, 2026
Timothy P SullivanDirector$500K–May 7, 2026
Meenal SethnaChief Financial Officer$327K–May 4, 2026
John Charles RademacherChief Executive Officer, Director$265K–May 4, 2026
Michael BavaroChief Human Resources Officer–$198KFeb 27, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

OPCH short interest

Low short interest. 4.1% of OPCH shares are sold short: about 1 share in 24. Over the last 12 reports the number of shares short went down 59%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 6.14M OPCH shares were sold short, 4.1% of the shares outstanding, down 13.7% from the report before. At the average daily volume of 3.41M shares, buying them all back would take about 1.8 trading days (days to cover).

Shares short, % of all shares

4.10%May 15Oct 3010.3%

Days to cover

1.8May 15Oct 308.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20266.14M4.10%-14%3.41M1.8
Oct 15, 20267.12M4.75%-17%11.08M1.0
Sep 30, 20268.56M5.72%-29%2.47M3.5
Sep 15, 202612.10M8.08%-4%1.61M7.5
Aug 31, 202612.67M8.46%+5%1.75M7.2
Aug 14, 202612.04M8.04%-8%2.29M5.3
Jul 31, 202613.02M8.69%-3%2.75M4.7
Jul 15, 202613.47M8.58%+2%2.06M6.5
Jun 30, 202613.24M8.43%+8%2.84M4.7
Jun 15, 202612.25M7.80%-3%2.97M4.1
May 29, 202612.59M8.02%-16%3.27M3.9
May 15, 202614.93M9.51%+36%5.32M2.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded OPCH

Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 2 sales of OPCH. The latest was a sale by Lisa C. McClain on Oct 31, 2025, reported Nov 21, 2025.

Purchases 2Sales 2

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Sep 25, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseOct 22, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Option Care Health company events

Option Care Health filed 10 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 6, 2026AgreementOption Care Health, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Onyx Bidco LLC, a Delaware limited liability company, and Onyx Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, pursuant to which the Company is to be acquired by an… Filing
  3. Jul 29, 2026ResultsReleased financial results. Filing
  4. May 22, 2026VoteReported shareholder vote results. Filing
  5. May 12, 2026AnnouncementShared information with investors. Filing
  6. May 5, 2026LeadershipOption Care Health, Inc. announced that Christopher L. Grashoff will depart from his role as Chief Growth Officer of the Company, effective May 8, 2026. Filing
  7. Apr 30, 2026ResultsReleased financial results. Filing
  8. Apr 2, 2026AgreementOption Care Health, Inc. entered into that certain Fifth Amendment to Amended and Restated First Lien Credit Agreement, by and among the Company, as borrower, certain subsidiaries of the Company party thereto, each Incremental Revolving Lender party thereto and Bank of America, N.A., as… Filing
  9. Feb 24, 2026ResultsReleased financial results. Filing
  10. Jan 12, 2026AnnouncementThe Company’s Board of Directors approved an increase to its 2025 share repurchase program authorization from $500 million to $1 billion. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Option Care Health financials

Famous investors that hold OPCH

6 of the 50 well-known investors we track reported holding OPCH in their latest 13F filing. The largest position is Steve Cohen's, worth $49.3M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 20262.19M$49.3M0.1%+22%
Israel Englander · Millennium ManagementQ3 20262.19M$49.2M0.0%-17%
Ken Griffin · Citadel AdvisorsQ3 20261.20M$26.9M0.0%-27%
Paul Tudor Jones · Tudor Investment CorpQ3 2026181,736$4.1M0.0%-24%
Ray Dalio · Bridgewater AssociatesQ3 202654,983$1.2M0.0%-50%
Jim Simons · Renaissance TechnologiesQ3 20269,200$207K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named OPCH in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Wellington Management Group LLP13G/A6.6%
Nov 16, 2026Wellington Management Group LLP13G/A6.6%
Oct 27, 2026BlackRock, Inc.13G/A13.1%
Oct 27, 2026BlackRock, Inc.13G/A13.1%

Questions about Option Care Health, Inc. (OPCH) stock

Who owns the most OPCH stock?

The largest reported owner of Option Care Health, Inc. (OPCH) is BlackRock, Inc., with 14.1% of the company. In total, 372 funds and institutions reported holding OPCH at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are OPCH insiders buying or selling?

In the last 12 months, OPCH insiders reported 4 open-market purchases worth $1.9M and 4 sales worth $1.4M. The latest trade was on Nov 11, 2026. See every trade.

What is the short interest in OPCH?

As of Oct 30, 2026, 6.14M OPCH shares were sold short, 4.1% of the shares outstanding, down 13.7% from the report before. At the average daily volume of 3.41M shares, buying them all back would take about 1.8 trading days (days to cover). See the history.

Have members of Congress traded OPCH?

Yes. 1 member of Congress reported 2 purchases and 2 sales of OPCH since Nov 17, 2024. The latest was reported on Nov 21, 2025. See the trades.

Which famous investors hold OPCH?

6 of the 50 well-known investors we track reported OPCH in their latest 13F filing, including Steve Cohen, Israel Englander, Ken Griffin. The largest position is worth $49.3M. See all holders.

Executive pay

Option Care Health's chief executive was paid a total of $9.3M for the year ended Dec 31, 2025, up 13% from $8.2M the year before. In the last 12 months, Option Care Health's executives and directors bought $1.9M of stock on the open market and sold $1.4M.

Chief executive, total pay$9.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$21.6MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.6MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.